// App-Quantinova.ai

: CXCR4 Blockade Targets Progression of Primary T Cell Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Anastasia N Tikhonova

Principal Investigators

  • N/A

Medical Centers

  • Princess Margaret Cancer Research Centre, University Health Network, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Annexin V

  • Neurogenic locus notch homolog protein 1

Drug/Treatment

  • Ulocuplumab

  • CXCL12

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved